Does Rallies show Form 4 insider transactions for AMPH?

Yes. Rallies tracks AMPH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is AMPH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AMPH. It does not provide personalized investment advice.

AMPH (Amphastar Pharmaceuticals, Inc.) Stock Analysis - Insider Trades

Amphastar Pharmaceuticals, Inc. (AMPH) is a publicly traded Healthcare sector company. As of May 21, 2026, AMPH trades at $18.08 with a market cap of $758.40M and a P/E ratio of 10.47. AMPH moved +1.35% today. Year to date, AMPH is -32.34%; over the trailing twelve months it is -27.88%. Its 52-week range spans $16.65 to $53.96. Analyst consensus is neutral with an average price target of $22.00. Rallies surfaces AMPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading AMPH stock inside the company?

Recent AMPH insider activity includes Zhou Rong sold 9.79K, Petersen Floyd F. sold 2.43K, Petersen Floyd F. sold 1.74K, PRINS RICHARD K sold 4.18K, and Petersen Floyd F. sold 16.68K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

AMPH Key Metrics

Key financial metrics for AMPH
Metric	Value
Price	$18.08
Market Cap	$758.40M
P/E Ratio	10.47
EPS	$1.71
Dividend Yield	0.00%
52-Week High	$53.96
52-Week Low	$16.65
Volume	0
Avg Volume	0
Revenue (TTM)	$720.53M
Net Income	$79.23M
Gross Margin	47.34%

Recent AMPH Insider Trades

Zhou Rong sold 9.79K (~$256.38K) on Dec 17, 2025.
Petersen Floyd F. sold 2.43K (~$62.89K) on Dec 12, 2025.
Petersen Floyd F. sold 1.74K (~$44.62K) on Dec 11, 2025.
PRINS RICHARD K sold 4.18K (~$113.25K) on Nov 25, 2025.
Petersen Floyd F. sold 16.68K (~$441.84K) on Nov 13, 2025.

Latest AMPH News

Amphastar Q1 EPS Drops to $0.42, Misses Consensus by $0.28 — May 7, 2026
Amphastar Sees Price Target Cut to $30, FDA Grants 180-Day Exclusivity — Mar 2, 2026
Amphastar Q4 Revenue Drops 1.8%, EPS Miss Leads to 15.8% Plunge — Feb 27, 2026
Amphastar Q4 Revenue Falls 2% as G&A Costs Surge 27% — Feb 27, 2026
Amphastar's 2025 Revenues Fall 2% on 45% Glucagon Drop, BAQSIMI Up 12% — Feb 27, 2026

AMPH Analyst Consensus

6 analysts cover AMPH: 0 strong buy, 0 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $22.00.

Common questions about AMPH

Who is trading AMPH stock inside the company?: Recent AMPH insider activity includes Zhou Rong sold 9.79K, Petersen Floyd F. sold 2.43K, Petersen Floyd F. sold 1.74K, PRINS RICHARD K sold 4.18K, and Petersen Floyd F. sold 16.68K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for AMPH?: Yes. Rallies tracks AMPH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is AMPH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AMPH. It does not provide personalized investment advice.